Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Lobucavir in AIDS Patients with CMV
NCT00002352Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of lobucavir in cytomegalovirus infection (CMV), sponsored by Bristol Myers Squibb. Status: completed.
02
Drugs
lobucavir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00002352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002352.